Empresa Flex Pharma Inc Nasdaq
Acciones
US33938A1051
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
David Arthur
CEO | Chief Executive Officer | 61 | 19/07/19 |
Mark Rosenblum
DFI | Director of Finance/CFO | 70 | 10/09/19 |
Bruce McCreedy
BRD | Director/Board Member | 64 | 19/07/19 |
Nadeem Q. Mirza
PRN | Corporate Officer/Principal | - | 23/07/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Arnold Hanish
BRD | Director/Board Member | 76 | 19/07/19 |
Paul Lammers
BRD | Director/Board Member | 66 | 19/07/19 |
Jonathan Lieber
BRD | Director/Board Member | 54 | 19/06/20 |
William McVicar
CHM | Chairman | 66 | 19/07/19 |
Bruce McCreedy
BRD | Director/Board Member | 64 | 19/07/19 |
Tess Burleson
BRD | Director/Board Member | 57 | 19/07/19 |
David Arthur
CEO | Chief Executive Officer | 61 | 19/07/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 4 776 433 | 4 486 213 ( 93,92 %) | 0 | 93,92 % |
Información de la empresa
Salarius Pharmaceuticals, Inc.
2450 Holcombe Boulevard Suite X
77021, Houston
+
http://salariuspharma.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+25,69 % | 47,9 mil M | |
+46,90 % | 41,42 mil M | |
-3,46 % | 40,7 mil M | |
-6,20 % | 28,92 mil M | |
+9,17 % | 25,55 mil M | |
-20,42 % | 19,27 mil M | |
+0,17 % | 12,15 mil M | |
+28,07 % | 12,14 mil M | |
-1,24 % | 11,99 mil M |